73933-19-4

Usage

Uses

Used in Pharmaceutical Industry:
(4-Benzyl-morpholin-2-yl)-acetic acid ethyl ester is used as a chemical intermediate for the synthesis of new drugs with potential analgesic and anti-inflammatory properties. Its unique structure and properties make it a valuable compound in the development of innovative therapeutic agents.
Used in Medical Research:
In the field of medical research, (4-Benzyl-morpholin-2-yl)-acetic acid ethyl ester serves as a valuable tool for studying the mechanisms of pain relief and inflammation reduction. Its potential applications in this area can contribute to the advancement of our understanding of these processes and the discovery of novel treatment options.

InChI:InChI=1/C15H21NO3/c1-2-18-15(17)10-14-12-16(8-9-19-14)11-13-6-4-3-5-7-13/h3-7,14H,2,8-12H2,1H3

Upstream product

• 104-63-2 N-Benzylethanolamine 
• 6065-32-3 4-bromocrotonic ethyl ester 
• 37746-78-4 4-bromo-trans-crotonic acid ethyl ester 

Downstream Products

• 112887-43-1 2-(2-hydroxyethyl)-4-benzylmorpholine 
• 1398371-20-4 2-(4-(2-(2-(((R)-1-(naphthalen-1-yl)ethyl)amino)ethyl)morpholino)phenoxy)acetic acid 
• 1005474-71-4 tert-butyl 2-(2-(tosyloxy)ethyl)morpholine-4-carboxylate 
• 766539-28-0 2-(4-(tert-butoxycarbonyl)morpholin-2-yl)acetic acid 
• 146944-27-6 4-benzylmorpholine-2-acetic acid 
• 1398495-52-7 4-((2-(2-(((R)-1-(naphthalen-1-yl)ethyl)amino)ethyl)morpholino)methyl)benzoic acid 
• 1398495-34-5 2-(4-(2-(2-(((R)-1-(naphthalen-1-yl)ethyl)amino)ethyl)morpholino)phenoxy)acetic acid 
• 503601-25-0 (±)-ethyl 2-(morpholin-2-yl)acetate 
• 132995-76-7 (2-hydroxyethyl)-morpholine 
• 1039033-19-6 C₂₃H₂₉N₃O₅S 

Relevant academic research and scientific papers

INDAZOLE BASED COMPOUNDS AND ASSOCIATED METHODS OF USE

Bifunctional compounds, which find utility as modulators of leucine-rich repeat kinase 2 (LRRK2), are described herein. In particular, the hetero-bifunctional compounds of the present disclosure contain on one end a moiety that binds to the cereblon E3 ubiquitin ligase and on the other end a moiety which binds LRRK2, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The hetero-bifunctional compounds of the present disclosure exhibit a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aberrant regulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

Novel anticancer compound and usage thereof

The invention provides a novel anticancer compound. The novel anticancer compound is a compound shown in chemical formula 1 in the description or pharmaceutically acceptable salt of the compound, andthe compound and the salt are active ingredients of a pharmaceutical composition for inhibiting the activity of hepatocyte growth factor receptor (c-Met) tyrosine kinase and pharmaceutical compositionfor preventing or curing excessive or abnormal proliferative diseases. The compound effectively inhibits the activity of the hepatocyte growth factor receptor tyrosine kinase, thereby being suitablefor treating the diseases with the characteristics of excessive or abnormal cell proliferation.

BENZO[B]FURANS AS BROMODOMAIN INHIBITORS

The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

PYRIDYL DERIVATIVES AS BROMODOMAIN INHIBITORS

The present invention relates to compounds of formula (I) and salts thereof, pharmaceutical compositions containing such compounds and to their use in therapy.

SUBSTITUTED MORPHOLINES AS MODULATORS FOR THE CALCIUM SENSING RECEPTOR

Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (CaSR) receptors. Methods of treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (CaSR) receptors of Formula (I).

SUBSTITUTED MORPHOLINES AS MODULATORS FOR THE CALCIUM SENSING RECEPTOR

Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (Ca SR) receptors. Methods of treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (Ca SR) receptors of Formula (I).